A New Class of Ibuprofen Derivatives with Reduced Gastrotoxicity-Reference-Cited by-同舟云学术

A New Class of Ibuprofen Derivatives with Reduced Gastrotoxicity

Published:2001-09-12 Issue:21 Volume:44 Page:3463-3468
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lolli Marco L.¹,Cena Clara¹,Medana Claudio¹,Lazzarato Loretta¹,Morini Giuseppina¹,Coruzzi Gabriella¹,Manarini Stefano¹,Fruttero Roberta¹,Gasco Alberto¹

Affiliation:

1. Dipartimento di Scienza e Tecnologia del Farmaco, Università degli Studi di Torino, via Pietro Giuria 9, 10125 Torino, Italy, and Istituto di Farmacologia, Università degli Studi di Parma, via Volturno 39, 43100 Parma, Italy, and Istituto di Ricerche Farmacologiche Mario Negri, Laboratorio di Interazione tra Cellule Ematiche e Vascolari, Dipartimento di Medicina e Farmacologia Vascolare, Consorzio Mario Negri Sud, 66030 Santa Maria Imbaro (CH), Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0108799

Reference29 articles.

1. The cellular and molecular basis of gastric mucosal defense

2. Nitric Oxide: A New Paradigm for Second Messengers

3. The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Molecular Consortia of Cannabidiol with Nonsteroidal Anti-Inflammatory Drugs Inhibit Emerging Coronaviruses’ Entry;Pathogens;2023-07-18

2. Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses;European Journal of Medicinal Chemistry;2023-03

3. New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs;Biomedicines;2023-01-12

4. Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells;Molecules;2022-10-05

5. Exploring ibuprofen derivatives as α‐glucosidase and lipoxygenase inhibitors: Cytotoxicity and in silico studies;Archiv der Pharmazie;2022-05-09